Home Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520
 

Keywords :   


Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520

2014-06-14 04:22:56| Biotech - Topix.net

Arrowhead Research Corporation , a biopharmaceutical company developing targeted RNAi therapeutics, today reaffirmed its belief that it has broad access to intellectual property required to develop ARC-520, its clinical candidate against chronic hepatitis B infection.

Tags: issues statement property protection

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »